| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |